EUVIMEDEUVIMED entdecken
Crossref

Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer’s Disease: A Bioinspired Alectinib Delivery Strategy

Ya-Ning Ding, Mei-Qi Li, Ping-Tian Ding, Pu Wang iD, Pei-Pei Guan

Nano Letters · 04.02.2026 · 26 (4) · 1181-1191

DOI: 10.1021/acs.nanolett.5c04420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, online erschienen am 20.10.2025. Verfasst von Ya-Ning Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life and Health Sciences, Northeastern University, Shenyang, P. R. China, 110819. Hauptthemen laut MEDLINE: Alzheimer Disease, Microglia, Carbazoles, Complement C1q. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Shenzhen Medical Research Fund, Natural Science Foundation of Top Talent of SZTU, Liaoning Provincial Department of Education Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant activation of the complement system drives early synaptic loss and chronic neuroinflammation in Alzheimer's disease (AD). Here, we identified complement component C1q as a key upregulated target in AD and screened Alectinib (ALE), an FDA-approved kinase inhibitor, as a high-affinity C1q binder. To achieve brain-targeted delivery, ALE was encapsulated in nanostructured lipid carriers camouflaged with microglial membranes (ALE@MM-NLCs). This biomimetic design enhanced blood-brain barrier (BBB) penetration and microglial uptake. In APP/PS1 mice, ALE@MM-NLCs improved cognitive performance and reduced C1q expression, β-amyloid (Aβ) burden, and glial activation, while promoting microglial M2-like polarization. Mechanistically, ALE@MM-NLCs suppressed oxidative stress, NLRP3 inflammasome activation, and C1q-mediated synaptosome phagocytosis, thereby preventing proteasome-dependent synaptic degradation. These results highlight ALE@MM-NLCs as a promising immunomodulatory nanotherapy for synaptic preservation and early AD intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMicrogliaCarbazolesComplement C1qPiperidinesAnimalsMiceBlood-Brain BarrierHumansDrug CarriersAmyloid beta-PeptidesSynapsesMice, Transgenic

Stichwörter der Autor:innen

Alzheimer’s diseaseBiomimetic nanocarriersComplement C1qMicrogliaSynaptic loss

Substanzen

CarbazolesComplement C1qPiperidinesDrug CarriersAmyloid beta-Peptides

Autor:innen und Institutionen

  • College of Life and Health Sciences, Northeastern University, Shenyang, P. R. China, 110819.
  • College of Pharmacy, Shenzhen Technology University, Shenzhen, P. R. China, 518118.

ORCID-Profile: Pu Wang

Förderung

  • Shenzhen Medical Research Fund
  • Natural Science Foundation of Top Talent of SZTU
  • Liaoning Provincial Department of Education Funding
  • Shenzhen Technology University
  • Department of Education of Liaoning Province

Zitieren

APA

Ding, Y. N., Li, M. Q., Ding, P. T., Wang, P., & Guan, P. P. (2026). Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer’s Disease: A Bioinspired Alectinib Delivery Strategy. Nano Letters, 26(4), 1181-1191. https://doi.org/10.1021/acs.nanolett.5c04420

Vancouver

Ding YN, Li MQ, Ding PT, Wang P, Guan PP. Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer’s Disease: A Bioinspired Alectinib Delivery Strategy. Nano Letters. 2026;26(4):1181-1191. doi:10.1021/acs.nanolett.5c04420

BibTeX
@article{Ding2026,
  author = {Ding, Ya-Ning and Li, Mei-Qi and Ding, Ping-Tian and Wang, Pu and Guan, Pei-Pei},
  title = {Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer’s Disease: A Bioinspired Alectinib Delivery Strategy},
  journal = {Nano Letters},
  year = {2026},
  volume = {26},
  number = {4},
  pages = {1181--1191},
  doi = {10.1021/acs.nanolett.5c04420}
}
Kostenlos starten →